Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

Dai, Z; Wong, IOL; Xie, C; Xu, W; Xiang, Y; Peng, L; Lau, Eric

Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

journal contribution

posted on 2024-06-02, 23:01 authored by Z Dai, IOL Wong, C Xie, W Xu, Y Xiang, L Peng, Eric LauEric Lau

Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

History

Related Materials

1.
DOI - Is version of https://doi.org/10.1016/j.cmi.2021.06.024

Location

Amsterdam, The Netherlands

Language

eng

Author URL

https://www.ncbi.nlm.nih.gov/pubmed/34197929

Publication classification

C1.1 Refereed article in a scholarly journal

Journal

Clinical Microbiology and Infection

Volume

28

Pagination

300-300

ISSN

1198-743X

eISSN

1469-0691

Issue

2

Publisher

Elsevier

Usage metrics

Keywords

Uncategorised value

Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China

History

Related Materials

Location

Language

Author URL

Publication classification

Journal

Volume

Pagination

ISSN

eISSN

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports